Ten years ago this month, on April 17, 2015, the U.S. government approved the Cure GM1 Foundation to be the first and only 501(c)(3) entirely dedicated to GM1 gangliosidosis research, drug development and awareness. Over the course of a decade, our efforts have grown significantly. What began as a more personal search for hope became a global movement that has transformed the landscape for this rare disease.
Carter’s story, by his mother “Carter Michael was diagnosed with GM1. He was our precious…
Help us make history by getting May 23rd, 2025 officially recognized as GM1 Gangliosidosis Awareness Day in your state! We’ve prepared all the materials you need – proclamation requests, supporting documents, and step-by-step guidance. Many states require submissions months in advance, so we need to start acting now!
Gael’s story, by his mother “Gael was diagnosed with Type 1 infantile GM1 on his…
This month is all about love, awareness, and action as we celebrate Valentine’s Day and Rare Disease Month. We are also celebrating our founder Christine’s daughter’s 17th birthday. For all families with children impacted by GM1, each birthday is a celebration, but the passage of time and the progression of the disease marks these milestones.
Cure GM1 is dedicated to investing in research, seeding new projects, and to the development of multiple treatment modalities for GM1 gangliosidosis. In collaboration with our advisors and consultants, who have decades of experience in biotech and research, Cure GM1 has selected a contract research organization (CRO) to further the development of enzyme replacement therapy (ERT).
Milah’s story, by her mother “Milah was diagnosed with GM1 Type 1 at 8 months…
Thank you for an amazing year in 2024!
The impact of your support gives hope to children, brings comfort to families, and accelerates the research that could change lives. Your support means that not a single moment will be lost in our pursuit of better treatments and support for families affected by GM1.
Our summary of impact in 2024 is now available to read. Although this year was hard with…